Publications 2020

  1. Alferink LJ, Radjabzadeh D, Erler NS, Vojinovic D, Medina-Gomez C, Uitterlinden AG, Knegt RJ, Amin N, Ikram MA, Janssen H, Kiefte-deJong JC, Metselaar HJ, Duijn CMV, Kraaij R, Darwish Murad S. Microbiomics, Metabolomics, Predicted Metagenomics and Hepatic Steatosis in a Population-Based Study of 1355 Adults. Hepatology. 2020.

  2. Alferink LJM, Erler NS, de Knegt RJ, Janssen HLA, Metselaar HJ, Darwish Murad S, Kiefte-de Jong JC. Adherence to a Plant-Based, High-Fibre Dietary Pattern Is Related to Regression of Non-Alcoholic Fatty Liver Disease in an Elderly Population. Eur J Epidemiol. 2020;35(11):1069-85.

  3. Barnhoorn MC, Wasser M, Roelofs H, Maljaars PWJ, Molendijk I, Bonsing BA, Oosten LEM, Dijkstra G, van der Woude CJ, Roelen DL, Zwaginga JJ, Verspaget HW, Fibbe WE, Hommes DW, Peeters K, van der Meulen-de Jong AE. Long-Term Evaluation of Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cell Therapy for Crohn's Disease Perianal Fistulas. J Crohns Colitis. 2020;14(1):64-70.

  4. Beelen EMJ, van der Woude CJ, de Vries AC. Intestinal Resection Rates in Crohn's Disease Decline across Two Different Epidemiological Areas: A Consistent Observation Not Merely Due to Introduction of Anti-Tnfalpha. Gut. 2020;69(9):1.

  5. Beudeker BJ, Groothuismink ZM, de Man RA, Janssen H, van der Eijk AA, Boonstra A, Sonneveld MJ. Hepatitis B Core-Related Antigen Levels Predict Pegylated Interferon-Alpha Therapy Response in Hbeag-Positive Chronic Hepatitis B. Antivir Ther. 2020.

  6. Beudeker BJB, Boonstra A. Circulating Biomarkers for Early Detection of Hepatocellular Carcinoma. Therap Adv Gastroenterol. 2020;13:1756284820931734.

  7. Biemans VBC, Sleutjes JAM, de Vries AC, Bodelier AGL, Dijkstra G, Oldenburg B, Lowenberg M, van Bodegraven AA, van der Meulen-de Jong AE, de Boer NKH, Srivastava N, West RL, Romkens TEH, Horjus Talabur Horje CS, Jansen JM, van der Woude CJ, Hoekstra J, Weersma RK, van Schaik FDM, Hoentjen F, Pierik MJ, Dutch Initiative on C, Colitis. Tofacitinib for Ulcerative Colitis: Results of the Prospective Dutch Initiative on Crohn and Colitis (Icc) Registry. Aliment Pharmacol Ther. 2020;51(9):880-8.

  8. Biemans VBC, van der Meulen-de Jong AE, van der Woude CJ, Lowenberg M, Dijkstra G, Oldenburg B, de Boer NKH, van der Marel S, Bodelier AGL, Jansen JM, Haans JJL, Theeuwen R, de Jong D, Pierik MJ, Hoentjen F. Ustekinumab for Crohn's Disease: Results of the Icc Registry, a Nationwide Prospective Observational Cohort Study. J Crohns Colitis. 2020;14(1):33-45.

  9. Biemans VBC, van der Woude CJ, Dijkstra G, van der Meulen-de Jong AE, Oldenburg B, de Boer NK, Lowenberg M, Srivastava N, Bodelier AGL, West RL, Jansen JM, de Vries AC, Haans JJL, de Jong DJ, Pierik MJ, Hoentjen F. Vedolizumab for Inflammatory Bowel Disease: Two-Year Results of the Initiative on Crohn and Colitis (Icc) Registry, a Nationwide Prospective Observational Cohort Study: Icc Registry - Vedolizumab. Clin Pharmacol Ther. 2020;107(5):1189-99.

  10. Bleijenberg AG, JE IJ, van Herwaarden YJ, Carballal S, Pellise M, Jung G, Bisseling TM, Nagtegaal ID, van Leerdam ME, van Lelyveld N, Bessa X, Rodriguez-Moranta F, Bastiaansen B, de Klaver W, Rivero L, Spaander MC, Koornstra JJ, Bujanda L, Balaguer F, Dekker E. Personalised Surveillance for Serrated Polyposis Syndrome: Results from a Prospective 5-Year International Cohort Study. Gut. 2020;69(1):112-21.

  11. Bleijenberg AGC, van Leerdam ME, Bargeman M, Koornstra JJ, van Herwaarden YJ, Spaander MC, Sanduleanu S, Bastiaansen BAJ, Schoon EJ, van Lelyveld N, Dekker E, JEG IJ. Substantial and Sustained Improvement of Serrated Polyp Detection after a Simple Educational Intervention: Results from a Prospective Controlled Trial. Gut. 2020;69(12):2150-8.

  12. Boeijen LL, Spaan M, Boonstra A. The Effects of Nucleoside/Nucleotide Analogues on Host Immune Cells: The Baseline for Future Immune Therapy for Hbv? Antivir Ther. 2020.

  13. Boor PPC, Sideras K, Biermann K, Hosein Aziz M, Levink IJM, Mancham S, Erler NS, Tang X, van Eijck CH, Bruno MJ, Sprengers D, Zang X, Kwekkeboom J. Hhla2 Is Expressed in Pancreatic and Ampullary Cancers and Increased Expression Is Associated with Better Post-Surgical Prognosis. Br J Cancer. 2020;122(8):1211-8.

  14. Borgsteede SD, Weersink RA, Geijteman E, Metselaar HJ, Hunfeld NGM. Recommendations for Safe Medication Use in Liver Impairment: Importance of Transparency and Reflections on Analgesics, Hypnotics, and Anti-Emetics. J Pain Symptom Manage. 2020;59(3):e6-e8.

  15. Borren NZ, Paulides E, Frinack JL, Olson RN, Willrich MAV, van der Woude CJ, Ananthakrishnan AN. Infliximab Trough Levels Are Not Predictive of Relapse in Patients with Ibd in Endoscopic Remission: A Multicenter Cohort Study. Dig Dis Sci. 2020.

  16. Borren NZ, Tan W, Colizzo FP, Luther J, Garber JJ, Khalili H, van Der Woude CJ, Ananthakrishnan AN. Longitudinal Trajectory of Fatigue with Initiation of Biologic Therapy in Inflammatory Bowel Diseases: A Prospective Cohort Study. J Crohns Colitis. 2020;14(3):309-15.

  17. Boxhoorn L, Fritzsche JA, Fockens P, van Hooft JE, de Jonge PJF, Poley JW, Bruno MJ, Voermans RP. Clinical Outcome of Endoscopic Treatment for Symptomatic Sterile Walled-Off Necrosis. Endoscopy. 2020.

  18. Boxhoorn L, Voermans RP, Bouwense SA, Bruno MJ, Verdonk RC, Boermeester MA, van Santvoort HC, Besselink MG. Acute Pancreatitis. Lancet. 2020;396(10252):726-34.

  19. Brand EC, Elias SG, Minderhoud IM, van der Veen JJ, Baert FJ, Laharie D, Bossuyt P, Bouhnik Y, Buisson A, Lambrecht G, Louis E, Pariente B, Pierik MJ, van der Woude CJ, D'Haens G, Vermeire S, Oldenburg B, Dutch Initiative on C, Colitis. Systematic Review and External Validation of Prediction Models Based on Symptoms and Biomarkers for Identifying Endoscopic Activity in Crohn's Disease. Clin Gastroenterol Hepatol. 2020;18(8):1704-18.

  20. Broker MEE, Taimr P, de Vries M, Braun LMM, de Man RA, Ijzermans JNM, Dwarkasing RS. Performance of Contrast-Enhanced Sonography Versus Mri with a Liver-Specific Contrast Agent for Diagnosis of Hepatocellular Adenoma and Focal Nodular Hyperplasia. AJR Am J Roentgenol. 2020;214(1):81-9.

  21. Bruno MJ. Lams for All Pancreatic Fluid Collections? Endosc Int Open. 2020;8(9):E1161-E2.

  22. Choi HSJ, Brouwer WP, Zanjir WMR, de Man RA, Feld JJ, Hansen BE, Janssen HLA, Patel K. Nonalcoholic Steatohepatitis Is Associated with Liver-Related Outcomes and All-Cause Mortality in Chronic Hepatitis B. Hepatology. 2020;71(2):539-48.

  23. Choi HSJ, van Campenhout MJH, van Vuuren AJ, Krassenburg LAP, Sonneveld MJ, de Knegt RJ, Hansen BE, Janssen HLA. Ultra Long-Term Follow-up of Interferon-Alpha Treatment for Hbeag-Positive Chronic Hepatitis B Virus Infection. Clin Gastroenterol Hepatol. 2020.

  24. de Beijer MTA, Jansen D, Dou Y, van Esch WJE, Mok JY, Maas MJP, Brasser G, de Man RA, Woltman AM, Buschow SI. Discovery and Selection of Hepatitis B Virus-Derived T Cell Epitopes for Global Immunotherapy Based on Viral Indispensability, Conservation, and Hla-Binding Strength. J Virol. 2020;94(7).

  25. de Goede B, van Rooijen MMJ, van Kempen BJH, Polak WG, de Man RA, Taimr P, Lange JF, Metselaar HJ, Kazemier G. Conservative Treatment Versus Elective Repair of Umbilical Hernia in Patients with Liver Cirrhosis and Ascites: Results of a Randomized Controlled Trial (Crucial Trial). Langenbecks Arch Surg. 2020.

  26. de Jong DM, Poley JW, Bruno MJ, de Jonge PJF. Uncommon Cause of Cholangitis Due to a Migrated Pancreatic Stone into the Common Bile Duct. VideoGIE. 2020;5(12):667-9.

  27. de Knegt RJ, Potthoff A, Wirth T. [Management of Benign Liver Tumors]Management Benigner Lebertumoren. Internist (Berl). 2020;61(2):140-6.

  28. De Lima-Karagiannis A, Juillerat P, Sebastian S, Pedersen N, Bar-Gil Shitrit A, van der Woude CJ. Management of Pregnant Inflammatory Bowel Disease Patients During the Covid-19 Pandemic. J Crohns Colitis. 2020;14(Supplement_3):S807-S14.

  29. de Neree Tot Babberich MPM, Ledeboer M, van Leerdam ME, Spaander MCW, van Esch AAJ, Ouwendijk RJ, van der Schaar PJ, van der Beek S, Lacle MM, Seegers PA, Wouters M, Fockens P, Dekker E. Dutch Gastrointestinal Endoscopy Audit: Automated Extraction of Colonoscopy Data for Quality Assessment and Improvement. Gastrointest Endosc. 2020;92(1):154-62 e1.

  30. de Rijk FE, Kempeneers MA, Bruno MJ, Besselink MG, van Goor H, Boermeester MA, van Geenen EJ, van Hooft JE, van Santvoort HC, Verdonk RC, Dutch Pancreatitis Study G. Suboptimal Care for Chronic Pancreatitis Patients Revealed by Moderate to Low Adherence to the United European Gastroenterology Evidence-Based Guidelines (Hapaneu): A Netherlands Nationwide Analysis. United European Gastroenterol J. 2020;8(7):764-74.

  31. de Vries-Sluijs T, Andrinopoulou ER, de Man RA, van der Ende ME. Fendrix(R) Compared to Engerix(R) in Hiv-Infected Patients Nonresponding to Initial- and Re-Vaccination Schedule. Neth J Med. 2020;78(6):376-80.

  32. Debes JD, Boonstra A, de Knegt RJ. Nafld-Related Hepatocellular Carcinoma and the Four Horsemen of the Apocalypse. Hepatology. 2020;71(3):774-6.

  33. Debes JD, Groothuismink ZMA, de Man RA, Boonstra A. Association between a Progesterone Receptor Mutation and Hepatitis E Sero-Positivity in Liver Transplant Recipients. J Med Virol. 2020.

  34. Debes JD, van Oord G, Boonstra A. Validation of Whole Blood Rapid Diagnosis Test for Hepatitis B. Ann Glob Health. 2020;86(1):53.

  35. Deijl W, Arkenbosch J, van Ruler O, van der Woude CJ, Stevens H, de Graaf E, Schouten R. Autologous Platelet-Rich Stroma in Complex Perianal Fistulas. Dis Colon Rectum. 2020;63(6):860-1.

  36. Doornekamp L, Goetgebuer RL, Schmitz KS, Goeijenbier M, van der Woude CJ, Fouchier R, van Gorp ECM, de Vries AC. High Immunogenicity to Influenza Vaccination in Crohn's Disease Patients Treated with Ustekinumab. Vaccines (Basel). 2020;8(3).

  37. Dou Y, Jansen D, van den Bosch A, de Man RA, van Montfoort N, Araman C, van Kasteren SI, Zom GG, Krebber WJ, Melief CJM, Woltman AM, Buschow SI. Design of Tlr2-Ligand-Synthetic Long Peptide Conjugates for Therapeutic Vaccination of Chronic Hbv Patients. Antiviral Res. 2020;178:104746.

  38. Dreesen E, Baert F, Laharie D, Bossuyt P, Bouhnik Y, Buisson A, Lambrecht G, Louis E, Oldenburg B, Pariente B, Pierik M, van der Woude CJ, D'Haens G, Vermeire S, Gils A. Monitoring a Combination of Calprotectin and Infliximab Identifies Patients with Mucosal Healing of Crohn's Disease. Clin Gastroenterol Hepatol. 2020;18(3):637-46 e11.

  39. Eyck BM, Onstenk BD, Noordman BJ, Nieboer D, Spaander MCW, Valkema R, Lagarde SM, Wijnhoven BPL, van Lanschot JJB. Accuracy of Detecting Residual Disease after Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Systematic Review and Meta-Analysis. Ann Surg. 2020;271(2):245-56.

  40. Farag MS, van Campenhout MJH, Pfefferkorn M, Fischer J, Deichsel D, Boonstra A, van Vuuren AJ, Ferenci P, Feld JJ, Berg T, Hansen BE, van Bommel F, Janssen HLA. Hepatitis B Virus Rna as Early Predictor for Response to Pegylated Interferon Alfa in Hbeag Negative Chronic Hepatitis B. Clin Infect Dis. 2020.

  41. Faria AVS, Andrade SS, Reijm AN, Spaander MCW, de Maat MPM, Peppelenbosch MP, Ferreira-Halder CV, Fuhler GM. Correction: Faria, A.V.S. Et Al., Targeting Tyrosine Phosphatases by 3-Bromopyruvate Overcomes Hyperactivation of Platelets from Gastrointestinal Cancer Patients. J. Clin. Med. 2019, 8, 936. J Clin Med. 2020;9(8).

  42. Gaspersz MP, Klompenhouwer AJ, Broker MEE, Thomeer MGJ, van Aalten SM, Steegers E, Terkivatan T, de Koning H, de Man RA, Ijzermans JNM. Growth of Hepatocellular Adenoma During Pregnancy: A Prospective Study. J Hepatol. 2020;72(1):119-24.

  43. Ghalandari N, Dolhain R, Hazes JMW, Siezen CLE, van der Laan JW, Crijns H, van Puijenbroek EP, van der Woude CJ. The Pre- and Post-Authorisation Data Published by the European Medicines Agency on the Use of Biologics During Pregnancy and Lactation. Br J Clin Pharmacol. 2020;86(3):580-90.

  44. Gijsbers KM, Post Z, Schrauwen RWM, Tang TJ, Bisseling TM, Bac DJ, Veenstra RP, Schreuder RM, Epping Stippel LSM, de Vos Tot Nederveen Cappel WH, Slangen RME, van Lelyveld N, Witteman EM, van Milligen de Wit M, Honkoop P, Alderlieste Y, Ter Borg PJC, van Roermund R, Schmittgens S, Dekker E, Leeuwenburgh I, de Ridder RJJ, Zonneveld AM, Hadithi M, van Leerdam ME, Bruno MJ, Vleggaar FP, Moons LMG, Koch AD, Ter Borg F. Low Value of Second-Look Endoscopy for Detecting Residual Colorectal Cancer after Endoscopic Removal. Gastrointest Endosc. 2020;92(1):166-72.

  45. Goverde A, Eikenboom EL, Viskil EL, Bruno MJ, Doukas M, Dinjens WNM, Dubbink EJ, van den Ouweland AMW, Hofstra RMW, Wagner A, Spaander MCW. Yield of Lynch Syndrome Surveillance for Patients with Pathogenic Variants in DNA Mismatch Repair Genes. Clin Gastroenterol Hepatol. 2020;18(5):1112-20 e1.

  46. Greuter MJ, Carvalho B, Wit M, Dekker E, Spaander MC, Meijer GA, Engeland MV, Coupe VM. Can a Biomarker Triage Test Reduce Colonoscopy Burden in Fecal Immunochemical Test Screening? J Comp Eff Res. 2020;9(8):563-71.

  47. Grobbee EJ, Lam SY, Fuhler GM, Blakaj B, Konstantinov SR, Bruno MJ, Peppelenbosch MP, Kuipers EJ, Spaander MC. First Steps Towards Combining Faecal Immunochemical Testing with the Gut Microbiome in Colorectal Cancer Screening. United European Gastroenterol J. 2020;8(3):293-302.

  48. Grobbee EJ, van der Vlugt M, van Vuuren AJ, Stroobants AK, Mallant-Hent RC, Lansdorp-Vogelaar I, Bossuyt PMM, Kuipers EJ, Dekker E, Spaander MCW. Diagnostic Yield of One-Time Colonoscopy Vs One-Time Flexible Sigmoidoscopy Vs Multiple Rounds of Mailed Fecal Immunohistochemical Tests in Colorectal Cancer Screening. Clin Gastroenterol Hepatol. 2020;18(3):667-75 e1.

  49. Hakim MS, Jariah ROA, Spaan M, Boonstra A. Interleukin 15 Upregulates the Expression of Pd-1 and Tim-3 on Cd4(+) and Cd8(+) T Cells.  Am J Clin Exp Immunol. 2020;9(3):10-21.

  50. Hallensleben ND, Umans DS, Bouwense SA, Verdonk RC, Romkens TE, Witteman BJ, Schwartz MP, Spanier MB, Laheij R, van Santvoort HC, Besselink MG, van Hooft JE, Bruno MJ, Dutch Pancreatitis Study G. The Diagnostic Work-up and Outcomes of 'Presumed' Idiopathic Acute Pancreatitis: A Post-Hoc Analysis of a Multicentre Observational Cohort. United European Gastroenterol J. 2020;8(3):340-50.

  51. Harms MH, de Veer RC, Lammers WJ, Corpechot C, Thorburn D, Janssen HLA, Lindor KD, Trivedi PJ, Hirschfield GM, Pares A, Floreani A, Mayo MJ, Invernizzi P, Battezzati PM, Nevens F, Ponsioen CY, Mason AL, Kowdley KV, Hansen BE, Buuren HRV, van der Meer AJ. Number Needed to Treat with Ursodeoxycholic Acid Therapy to Prevent Liver Transplantation or Death in Primary Biliary Cholangitis. Gut. 2020;69(8):1502-9.

  52. Harms MH, van Buuren HR, van der Meer AJ. Reply To: "Switching Vs. Add-on Strategy in Pbc Treatment: Lessons from Udca and Bezafibrate Experience". J Hepatol. 2020;72(6):1211-2.

  53. Hoek RAS, Manintveld OC, Betjes MGH, Hellemons ME, Seghers L, Van Kampen JAA, Caliskan K, van de Wetering J, van den Hoogen M, Metselaar HJ, Hesselink DA, Rotterdam Transplant G. Covid-19 in Solid Organ Transplant Recipients: A Single-Center Experience. Transpl Int. 2020;33(9):1099-105.

  54. Hoogeveen RC, Boonstra A. Checkpoint Inhibitors and Therapeutic Vaccines for the Treatment of Chronic Hbv Infection. Front Immunol. 2020;11:401.

  55. Ikram MA, Brusselle G, Ghanbari M, Goedegebure A, Ikram MK, Kavousi M, Kieboom BCT, Klaver CCW, de Knegt RJ, Luik AI, Nijsten TEC, Peeters RP, van Rooij FJA, Stricker BH, Uitterlinden AG, Vernooij MW, Voortman T. Objectives, Design and Main Findings until 2020 from the Rotterdam Study. Eur J Epidemiol. 2020;35(5):483-517.

  56. Isfordink CJ, Brakenhoff SM, van Dijk M, van der Valk M, de Knegt RJ, Arends JE, Drenth JP, HepNed study g. Hepatitis C Elimination in the Netherlands (Celine): Study Protocol for Nationwide Retrieval of Lost to Follow-up Patients with Chronic Hepatitis C. BMJ Open Gastroenterol. 2020;7(1):e000396.

  57. Issa Y, Kempeneers MA, Bruno MJ, Fockens P, Poley JW, Ahmed Ali U, Bollen TL, Busch OR, Dejong CH, van Duijvendijk P, van Dullemen HM, van Eijck CH, van Goor H, Hadithi M, Haveman JW, Keulemans Y, Nieuwenhuijs VB, Poen AC, Rauws EA, Tan AC, Thijs W, Timmer R, Witteman BJ, Besselink MG, van Hooft JE, van Santvoort HC, Dijkgraaf MG, Boermeester MA, Dutch Pancreatitis Study G. Effect of Early Surgery Vs Endoscopy-First Approach on Pain in Patients with Chronic Pancreatitis: The Escape Randomized Clinical Trial. JAMA. 2020;323(3):237-47.

  58. Jansen JC, van Hoek B, Metselaar HJ, van den Berg AP, Zijlstra F, Huijben K, van Scherpenzeel M, Drenth JPH, Lefeber DJ. Screening for Abnormal Glycosylation in a Cohort of Adult Liver Disease Patients. J Inherit Metab Dis. 2020;43(6):1310-20.

  59. Kamar N, Abravanel F, Behrendt P, Hofmann J, Pageaux GP, Barbet C, Moal V, Couzi L, Horvatits T, De Man RA, Cassuto E, Elsharkawy AM, Riezebos-Brilman A, Scemla A, Hillaire S, Donnelly MC, Radenne S, Sayegh J, Garrouste C, Dumortier J, Glowaki F, Matignon M, Coilly A, Figueres L, Mousson C, Minello A, Dharancy S, Rerolle JP, Lebray P, Etienne I, Perrin P, Choi M, Marion O, Izopet J, Hepatitis EVRSG. Ribavirin for Hepatitis E Virus Infection after Organ Transplantation: A Large European Retrospective Multicenter Study. Clin Infect Dis. 2020;71(5):1204-11.

  60. Kanis SL, Modderman S, Escher JC, Erler N, Beukers R, de Boer N, Bodelier A, Depla A, Dijkstra G, van Dijk ARM, Gilissen L, Hoentjen F, Jansen JM, Kuyvenhoven J, Mahmmod N, Mallant-Hent RC, van der Meulen-de Jong AE, Noruzi A, Oldenburg B, Oostenbrug LE, Ter Borg PCJ, Pierik M, Romberg-Camps M, Thijs W, West R, de Lima A, van der Woude CJ, Initiative on C, Colitis. Health Outcomes of 1000 Children Born to Mothers with Inflammatory Bowel Disease in Their First 5 Years of Life. Gut. 2020.

  61. Kempeneers MA, Ahmed Ali U, Issa Y, van Goor H, Drenth JPH, van Dullemen HM, van Hooft JE, Poen AC, van Veldhuisen SL, Besselink MG, van Santvoort HC, Bruno MJ, Boermeester MA, Dutch Pancreatitis Study G. Natural Course and Treatment of Pancreatic Exocrine Insufficiency in a Nationwide Cohort of Chronic Pancreatitis. Pancreas. 2020;49(2):242-8. Kempeneers MA, Bruno MJ, Boermeester MA. Surgery Vs Endoscopy for Early Treatment of Chronic Pancreatitis-Reply. JAMA. 2020;323(21):2203.

  62. Kessler AL, Bruno MJ, Buschow SI. The Potential of Soluble Human Leukocyte Antigen Molecules for Early Cancer Detection and Therapeutic Vaccine Design. Vaccines (Basel). 2020;8(4).

  63. Kirkegaard-Klitbo DM, Bendtsen F, Lundgren J, de Knegt RJ, Kofoed KF, Nielsen SD, Benfield T. Increased Prevalence of Liver Fibrosis in People Living with Hiv without Viral Hepatitis Compared to Population Controls. J Infect Dis. 2020.

  64. Klompenhouwer AJ, Alblas M, van Rosmalen BV, Haring MPD, Venema E, Doukas M, Thomeer MGJ, Takkenberg RB, Verheij J, de Meijer VE, van Gulik TM, Lingsma HF, de Man RA, Ijzermans JNM. Response to Chen Et Al. Am J Gastroenterol. 2020;115(1):147-8.

  65. Klompenhouwer AJ, de Man RA, Dioguardi Burgio M, Vilgrain V, Zucman-Rossi J, Ijzermans JNM. New Insights in the Management of Hepatocellular Adenoma. Liver Int. 2020;40(7):1529-37.

  66. Klompenhouwer AJ, Dwarkasing RS, Doukas M, Pellegrino S, Vilgrain V, Paradis V, Soubrane O, Beane JD, Geller DA, Nalesnik MA, Tripke V, Lang H, Schmelzle M, Pratschke J, Schoning W, Beal E, Sun S, Pawlik TM, de Man RA, Ijzermans JNM. Hepatic Angiomyolipoma: An International Multicenter Analysis on Diagnosis, Management and Outcome. HPB (Oxford). 2020;22(4):622-9.

  67. Klompenhouwer AJ, van Rosmalen BV, Haring MPD, Thomeer MGJ, Doukas M, Verheij J, de Meijer VE, van Gulik TM, Takkenberg RB, Kazemier G, Nevens F, de Man RA, Ijzermans JNM. A Multicentre Retrospective Analysis on Growth of Residual Hepatocellular Adenoma after Resection. Liver Int. 2020;40(9):2272-8.

  68. Kooyker AI, Toes-Zoutendijk E, Opstal-van Winden AWJ, Buskermolen M, van Vuuren HJ, Kuipers EJ, van Kemenade FJ, Ramakers C, Dekker E, Nagtegaal ID, de Koning HJ, Spaander MCW, Lansdorp-Vogelaar I, van Leerdam ME. Colonoscopy-Related Mortality in a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program. Clin Gastroenterol Hepatol. 2020.

  69. Kooyker AI, Toes-Zoutendijk E, Opstal-van Winden AWJ, Spaander MCW, Buskermolen M, van Vuuren HJ, Kuipers EJ, van Kemenade FJ, Ramakers C, Thomeer MGJ, Dekker E, Nagtegaal ID, de Koning HJ, van Leerdam ME, Lansdorp-Vogelaar I. The Second Round of the Dutch Colorectal Cancer Screening Program: Impact of an Increased Fecal Immunochemical Test Cut-Off Level on Yield of Screening. Int J Cancer. 2020;147(4):1098-106.

  70. Krassenburg LAP, Maan R, Ramji A, Manns MP, Cornberg M, Wedemeyer H, de Knegt RJ, Hansen BE, Janssen HLA, de Man RA, Feld JJ, van der Meer AJ. Clinical Outcomes Following Daa Therapy in Patients with Hcv-Related Cirrhosis Depend on Disease Severity. J Hepatol. 2020.

  71. Kreijne JE, de Vries AC, de Veer RC, Bouma G, Dijkstra G, Voskuil MD, West R, van Moorsel SAW, de Jong DJ, de Boer NK, van der Woude CJ, initiative on C, Colitis. Limited Added Value of Laboratory Monitoring in Thiopurine Maintenance Monotherapy in Inflammatory Bowel Disease Patients. Aliment Pharmacol Ther. 2020;51(12):1353-64.

  72. Labeur TA, Berhane S, Edeline J, Blanc JF, Bettinger D, Meyer T, Van Vugt JLA, Ten Cate DWG, De Man RA, Eskens F, Cucchetti A, Bonnett LJ, Van Delden OM, Klumpen HJ, Takkenberg RB, Johnson PJ. Improved Survival Prediction and Comparison of Prognostic Models for Patients with Hepatocellular Carcinoma Treated with Sorafenib. Liver Int. 2020;40(1):215-28.

  73. Lakhtakia S, Reddy N, Dolak W, Ponchon T, Bruno MJ, Bourke MJ, Neuhaus H, Roy A, Gonzalez-Huix Llado F, Kortan PP, Peetermans J, Rousseau M, Costamagna G, Deviere J, Benign Biliary Stenoses Working G. Long-Term Outcomes after Temporary Placement of a Self-Expanding Fully Covered Metal Stent for Benign Biliary Strictures Secondary to Chronic Pancreatitis. Gastrointest Endosc. 2020;91(2):361-9 e3.

  74. Lantinga MA, Theunissen F, Ter Borg PCJ, Bruno MJ, Ouwendijk RJT, Siersema PD, Trans ITfsg. Impact of the Covid-19 Pandemic on Gastrointestinal Endoscopy in the Netherlands: Analysis of a Prospective Endoscopy Database. Endoscopy. 2020.

  75. Laschtowitz A, de Veer RC, Van der Meer AJ, Schramm C. Diagnosis and Treatment of Primary Biliary Cholangitis. United European Gastroenterol J. 2020;8(6):667-74.

  76. Latenstein AEJ, Mackay TM, van Huijgevoort NCM, Bonsing BA, Bosscha K, Hol L, Bruno MJ, van Coolsen MME, Festen S, van Geenen E, Groot Koerkamp B, Hemmink GJM, de Hingh I, Kazemier G, Lubbinge H, de Meijer VE, Molenaar IQ, Quispel R, van Santvoort HC, Seerden TCJ, Stommel MWJ, Venneman NG, Verdonk RC, Besselink MG, van Hooft JE, Dutch Pancreatic Cancer G. Nationwide Practice and Outcomes of Endoscopic Biliary Drainage in Resectable Pancreatic Head and Periampullary Cancer. HPB (Oxford). 2020.

  77. Levink IJM, Nesteruk K, Visser DI, Sieuwerts AM, Fernandes CJC, Jansen M, van Driel L, Poley JW, Peppelenbosch MP, Cahen DL, Fuhler GM, Bruno MJ. Optimization of Pancreatic Juice Collection: A First Step toward Biomarker Discovery and Early Detection of Pancreatic Cancer. Am J Gastroenterol. 2020;115(12):2103-8.

  78. Li P, Liu J, Li Y, Su J, Ma Z, Bramer WM, Cao W, de Man RA, Peppelenbosch MP, Pan Q. The Global Epidemiology of Hepatitis E Virus Infection: A Systematic Review and Meta-Analysis. Liver Int. 2020;40(7):1516-28.

  79. Li Y, Li P, Li Y, Zhang R, Yu P, Ma Z, Kainov DE, de Man RA, Peppelenbosch MP, Pan Q. Drug Screening Identified Gemcitabine Inhibiting Hepatitis E Virus by Inducing Interferon-Like Response Via Activation of Stat1 Phosphorylation. Antiviral Res. 2020;184:104967.

  80. Li Y, Qu C, Spee B, Zhang R, Penning LC, de Man RA, Peppelenbosch MP, Fieten H, Pan Q. Hepatitis E Virus Seroprevalence in Pets in the Netherlands and the Permissiveness of Canine Liver Cells to the Infection. Ir Vet J. 2020;73:6.

  81. Li Y, Yu P, Qu C, Li P, Li Y, Ma Z, Wang W, de Man RA, Peppelenbosch MP, Pan Q. Mda5 against Enteric Viruses through Induction of Interferon-Like Response Partially Via the Jak-Stat Cascade. Antiviral Res. 2020;176:104743.

  82. Lie M, Paulides E, van der Woude CJ. Patient Sex Does Not Affect Endoscopic Outcomes of Biologicals in Inflammatory Bowel Disease but Is Associated with Adverse Events. Int J Colorectal Dis. 2020;35(8):1489-500.

  83. Lynch KD, Chapman RW, Keshav S, Montano-Loza AJ, Mason AL, Kremer AE, Vetter M, de Krijger M, Ponsioen CY, Trivedi P, Hirschfield G, Schramm C, Liu CH, Bowlus CL, Estes DJ, Pratt D, Hedin C, Bergquist A, de Vries AC, van der Woude CJ, Yu L, Assis DN, Boyer J, Ytting H, Hallibasic E, Trauner M, Marschall HU, Daretti LM, Marzioni M, Yimam KK, Perin N, Floreani A, Beretta-Piccoli BT, Rogers JK, International Primary Sclerosing Cholangitis Study G, Levy C. Effects of Vedolizumab in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2020;18(1):179-87 e6.

  84. Maan R, van der Meer AJ. Outcome of Direct-Acting Antiviral Treatment for Patients with Chronic Hepatitis C Virus Infection: Clinical Benefit Proven? Hepatobiliary Surg Nutr. 2020;9(2):257-9.

  85. Mackay TM, Latenstein AEJ, Bonsing BA, Bruno MJ, van Eijck CHJ, Groot Koerkamp B, de Hingh I, Homs MYV, van Hooft JE, van Laarhoven HW, Molenaar IQ, van Santvoort HC, Stommel MWJ, de Vos-Geelen J, Wilmink JW, Busch OR, van der Geest LG, Besselink MG. Nationwide Compliance with a Multidisciplinary Guideline on Pancreatic Cancer During 6-Year Follow-Up. Pancreatology. 2020;20(8):1723-31.

  86. Magro F, Rahier JF, Abreu C, MacMahon E, Hart A, van der Woude CJ, Gordon H, Adamina M, Viget N, Vavricka S, Kucharzik T, Leone S, Siegmund B, Danese S, Peyrin-Biroulet L. Inflammatory Bowel Disease Management During the Covid-19 Outbreak: The Ten Do's and Don'ts from the Ecco-Covid Taskforce. J Crohns Colitis. 2020;14(Supplement_3):S798-S806. Metselaar HJ, Porte RJ, JNM IJ. [the Place of Living-Donor Liver Transplants in the Netherlands] De Plaats Van Levertransplantatie Met Levende Donor in Nederland.  Ned Tijdschr Geneeskd. 2020;164.

  87. Murillo Perez CF, Gulamhusein A, Carbone M, Trivedi PJ, van der Meer AJ, Corpechot C, Battezzati PM, Lammers WJ, Cazzagon N, Floreani A, Pares A, Nevens F, Lleo A, Mayo MJ, Kowdley KV, Ponsioen CY, Dalekos GN, Gatselis NK, Thorburn D, Mason AL, Janssen H, Verhelst X, Bruns T, Lindor KD, Chazouilleres O, Invernizzi P, Hansen BE, Hirschfield GM, Group GPS. Simplified Care-Pathway Selection for Nonspecialist Practice: The Global Primary Biliary Cholangitis Study Group Age, Bilirubin, Alkaline Phosphatase Risk Assessment Tool. Eur J Gastroenterol Hepatol. 2020.

  88. Murillo Perez CF, Harms MH, Lindor KD, van Buuren HR, Hirschfield GM, Corpechot C, van der Meer AJ, Feld JJ, Gulamhusein A, Lammers WJ, Ponsioen CY, Carbone M, Mason AL, Mayo MJ, Invernizzi P, Battezzati PM, Floreani A, Lleo A, Nevens F, Kowdley KV, Bruns T, Dalekos GN, Gatselis NK, Thorburn D, Trivedi PJ, Verhelst X, Pares A, Janssen HLA, Hansen BE, Group GPS. Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin within the Normal Range and Normalization of Alkaline Phosphatase. Am J Gastroenterol. 2020;115(7):1066-74.

  89. Muthusamy VR, Bruno MJ, Kozarek RA, Petersen BT, Pleskow DK, Sejpal DV, Slivka A, Peetermans JA, Rousseau MJ, Tirrell GP, Ross AS. Clinical Evaluation of a Single-Use Duodenoscope for Endoscopic Retrograde Cholangiopancreatography. Clin Gastroenterol Hepatol. 2020;18(9):2108-17 e3.

  90. N RM, Conceicao-Neto N, Van Den Wyngaert I, Van Oord GW, Groothuismink ZMA, Van Tilburg S, de Man RA, Aerssens J, Boonstra A. Differential Gene Expression in Peripheral Blood between Low Viremic Inactive Carrier and Nuc-Treated Hbv Patients Irrespective of Circulating Hbsag Levels. J Infect Dis. 2020.

  91. Oey RC, Aarts P, Erler NS, Metselaar HJ, Lakenman PLM, Riemslag Baas-van der Ree S, van Kemenade MC, van Buuren HR, de Man RA. Identification and Prognostic Impact of Malnutrition in a Population Screened for Liver Transplantation. Clin Nutr ESPEN. 2020;36:36-44.

  92. Omidvari AH, Roumans CAM, Naber SK, Kroep S, Wijnhoven BPL, Gaast AV, de Jonge PJ, Spaander MCW, Lansdorp-Vogelaar I. The Impact of the Policy-Practice Gap on Costs and Benefits of Barrett's Esophagus Management. Am J Gastroenterol. 2020;115(7):1026-35.

  93. Overbeek KA, Cahen DL, Kamps A, Konings I, Harinck F, Kuenen MA, Koerkamp BG, Besselink MG, van Eijck CH, Wagner A, Ausems MGE, van der Vlugt M, Fockens P, Vleggaar FP, Poley JW, van Hooft JE, Bleiker EMA, Bruno MJ, Dutch Familial Pancreatic Cancer Surveillance Study G. Patient-Reported Burden of Intensified Surveillance and Surgery in High-Risk Individuals under Pancreatic Cancer Surveillance. Fam Cancer. 2020;19(3):247-58.

  94. Overbeek KA, Krak NC, Pieters IC, Smits MM, Bent RM, Vendrik KEW, Tonneijck L, Muskiet MHA, van Raalte DH, Bruno MJ, Cahen DL. High Prevalence of Intraductal Papillary Mucinous Neoplasms in Type 2 Diabetes Mellitus Patients. Pancreas. 2020;49(1):e5-e7.

  95. Overbeek KA, Rodriguez-Girondo MD, Wagner A, van der Stoep N, van den Akker PC, Oosterwijk JC, van Os TA, van der Kolk LE, Vasen HFA, Hes FJ, Cahen DL, Bruno MJ, Potjer TP. Genotype-Phenotype Correlations for Pancreatic Cancer Risk in Dutch Melanoma Families with Pathogenic Cdkn2a Variants. J Med Genet. 2020.

  96. Paulides E, Boukema I, van der Woude CJ, de Boer NKH. The Effect of Psychotherapy on Quality of Life in Ibd Patients: A Systematic Review. Inflamm Bowel Dis. 2020.

  97. Pauwels RWM, de Vries AC, van der Woude CJ. Fecal Calprotectin Is a Reliable Marker of Endoscopic Response to Vedolizumab Therapy: A Simple Algorithm for Clinical Practice. J Gastroenterol Hepatol. 2020;35(11):1893-901.

  98. Peterse EFP, Naber SK, Daly C, Pollett A, Paszat LF, Spaander MCW, Aronson M, Gryfe R, Rabeneck L, Lansdorp-Vogelaar I, Baxter NN. Cost-Effectiveness of Active Identification and Subsequent Colonoscopy Surveillance of Lynch Syndrome Cases. Clin Gastroenterol Hepatol. 2020;18(12):2760-7 e12.

  99. Rauwers AW, Voor In 't Holt AF, Buijs JG, de Groot W, Erler NS, Bruno MJ, Vos MC. Nationwide Risk Analysis of Duodenoscope and Linear Echoendoscope Contamination. Gastrointest Endosc. 2020;92(3):681-91 e1.

  100. Regula J, Spaander MCW, Suchanek S, Kornowski A, Perrot V, Fischbach W, investigators DUS. A European, Multicentre, Observational, Post-Authorisation Safety Study of Oral Sulphate Solution: Compliance and Safety. Endosc Int Open. 2020;8(3):E247-E56.

  101. Reinders MTM, van Meer S, Burgmans MC, de Jong KP, Klumpen HJ, de Man RA, Ramsoekh DS, Sprengers D, Tjwa E, de Vos-Geelen J, van Erpecum KJ, van der Geest LGM, Dutch H, Cholangiocarcinoma G. Trends in Incidence, Diagnosis, Treatment and Survival of Hepatocellular Carcinoma in a Low-Incidence Country: Data from the Netherlands in the Period 2009-2016. Eur J Cancer. 2020;137:214-23.

  102. Ross AS, Bruno MJ, Kozarek RA, Petersen BT, Pleskow DK, Sejpal DV, Slivka A, Moore D, Panduro K, Peetermans JA, Insull J, Rousseau MJ, Tirrell GP, Muthusamy VR. Novel Single-Use Duodenoscope Compared with 3 Models of Reusable Duodenoscopes for Ercp: A Randomized Bench-Model Comparison. Gastrointest Endosc. 2020;91(2):396-403.

  103. Roumans CAM, van der Bogt RD, Steyerberg EW, Rizopoulos D, Lansdorp-Vogelaar I, Sharma P, Spaander MCW, Bruno MJ. Adherence to Recommendations of Barrett's Esophagus Surveillance Guidelines: A Systematic Review and Meta-Analysis. Endoscopy. 2020;52(1):17-28.

  104. Sari G, Meester EJ, van der Zee LC, Wouters K, van Lennep JR, Peppelenbosch M, Boonstra A, Van der Heiden K, Mulder MMT, Vanwolleghem T. A Mouse Model of Humanized Liver Shows a Human-Like Lipid Profile, but Does Not Form Atherosclerotic Plaque after Western Type Diet. Biochem Biophys Res Commun. 2020;524(2):510-5.

  105. Schepers NJ, Hallensleben NDL, Besselink MG, Anten MGF, Bollen TL, da Costa DW, van Delft F, van Dijk SM, van Dullemen HM, Dijkgraaf MGW, van Eijck CHJ, Erkelens GW, Erler NS, Fockens P, van Geenen EJM, van Grinsven J, Hollemans RA, van Hooft JE, van der Hulst RWM, Jansen JM, Kubben F, Kuiken SD, Laheij RJF, Quispel R, de Ridder RJJ, Rijk MCM, Romkens TEH, Ruigrok CHM, Schoon EJ, Schwartz MP, Smeets X, Spanier BWM, Tan A, Thijs WJ, Timmer R, Venneman NG, Verdonk RC, Vleggaar FP, van de Vrie W, Witteman BJ, van Santvoort HC, Bakker OJ, Bruno MJ, Dutch Pancreatitis Study G. Urgent Endoscopic Retrograde Cholangiopancreatography with Sphincterotomy Versus Conservative Treatment in Predicted Severe Acute Gallstone Pancreatitis (Apec): A Multicentre Randomised Controlled Trial. Lancet. 2020;396(10245):167-76.

  106. Scholten L, Latenstein AE, Aalfs CM, Bruno MJ, Busch OR, Bonsing BA, Koerkamp BG, Molenaar IQ, Ubbink DT, van Hooft JE, Fockens P, Glas J, DeVries JH, Besselink MG, Dutch Pancreatic Cancer G. Prophylactic Total Pancreatectomy in Individuals at High Risk of Pancreatic Ductal Adenocarcinoma (Propan): Systematic Review and Shared Decision-Making Programme Using Decision Tables. United European Gastroenterol J. 2020;8(8):865-77.

  107. Shen S, Wong GL, Kuang Z, van Campenhout MJH, Fan R, Wong VW, Yip TC, Chi H, Liang X, Hu X, Lin W, Wu Y, Liu X, Boonstra A, Hou J, Sun J, Chan HL. Development and Validation of a Model for Hepatitis B E Antigen Seroconversion in Entecavir-Treated Patients with Chronic Hepatitis B. J Med Virol. 2020;92(8):1206-13.

  108. Sleutjes JAM, de Vries AC, van der Woude CJ. Ozanimod in Crohn's Disease: A Promising New Player. Lancet Gastroenterol Hepatol. 2020;5(9):791-2.

  109. Sleutjes JAM, de Vries AC, van der Woude CJ, Roeters van Lennep JE. Lipid Profiles in Patients with Ulcerative Colitis Receiving Tofacitinib-Implications for Cardiovascular Risk and Patient Management. Inflamm Bowel Dis. 2020.

  110. Smits LJT, Pauwels RWM, Kievit W, de Jong DJ, de Vries AC, Hoentjen F, van der Woude CJ, group Ls. Lengthening Adalimumab Dosing Interval in Quiescent Crohn's Disease Patients: Protocol for the Pragmatic Randomised Non-Inferiority Ladi Study. BMJ Open. 2020;10(5):e035326.

  111. Sonneveld MJ, Brouwer WP, de Man RA. Hepatocellular Carcinoma Risk Stratification in Hbv Cirrhosis: Time to Turn the Page? J Hepatol. 2020;73(3):728-9.

  112. Sonneveld MJ, de Knegt RJ. Editorial: Rapid Disease Progression in Hepatitis Delta-Can We Turn the Tide? Aliment Pharmacol Ther. 2020;51(1):172-3.

  113. Sonneveld MJ, Hansen BE, Brouwer WP, Chan HL, Piratvisuth T, Jia JD, Zeuzem S, Chien RN, de Knegt RJ, Wat C, Pavlovic V, Gaggar A, Xie Q, Buti M, de Man RA, Janssen HLA, group S-BS. Hbsag Levels Can Be Used to Rule out Cirrhosis in Hbeag Positive Chronic Hepatitis B: Results from the Sonic-B Study. J Infect Dis. 2020.

  114. Sonneveld MJ, Park JY, Kaewdech A, Seto WK, Tanaka Y, Carey I, Papatheodoridi M, van Bommel F, Berg T, Zoulim F, Ahn SH, Dalekos GN, Erler NS, Honer Zu Siederdissen C, Wedemeyer H, Cornberg M, Yuen MF, Agarwal K, Boonstra A, Buti M, Piratvisuth T, Papatheodoridis G, Maasoumy B, Group CS. Prediction of Sustained Response after Nucleo(S)Tide Analogue Cessation Using Hbsag and Hbcrag Levels: A Multicenter Study (Create). Clin Gastroenterol Hepatol. 2020.

  115. Spada C, Hassan C, Bellini D, Burling D, Cappello G, Carretero C, Dekker E, Eliakim R, de Haan M, Kaminski MF, Koulaouzidis A, Laghi A, Lefere P, Mang T, Milluzzo SM, Morrin M, McNamara D, Neri E, Pecere S, Pioche M, Plumb A, Rondonotti E, Spaander MC, Taylor S, Fernandez-Urien I, van Hooft JE, Stoker J, Regge D. Imaging Alternatives to Colonoscopy: Ct Colonography and Colon Capsule. European Society of Gastrointestinal Endoscopy (Esge) and European Society of Gastrointestinal and Abdominal Radiology (Esgar) Guideline - Update 2020. Eur Radiol. 2020.

  116. Strijker M, Mackay TM, Bonsing BA, Bruno MJ, van Eijck CHJ, de Hingh I, Koerkamp BG, van Laarhoven HW, Molenaar IQ, van Santvoort HC, van Tienhoven G, Wilmink JW, Zeverijn S, Busch OR, Besselink MG. Establishing and Coordinating a Nationwide Multidisciplinary Study Group: Lessons Learned by the Dutch Pancreatic Cancer Group. Ann Surg. 2020;271(4):e102-e4.

  117. Suzuki L, Nieboer D, van Lanschot JJ, Spaander MC, Looijenga LH, Biermann K. Effect of Neoadjuvant Chemoradiotherapy on P53 and Sox2 Protein Expression in Esophageal Adenocarcinoma. Biomark Med. 2020;14(9):785-93.

  118. Takagi K, Domagala P, Porte RJ, Alwayn I, Metselaar HJ, van den Berg AP, van Hoek B, Ijzermans JNM, Polak WG. Liver Retransplantation in Adult Recipients: Analysis of a 38-Year Experience in the Netherlands. J Hepatobiliary Pancreat Sci. 2020;27(1):26-33.

  119. Ten Kate CA, Tambucci R, Vlot J, Spaander MCW, Gottrand F, Wijnen RMH, Dall'Oglio L. An International Survey on Anastomotic Stricture Management after Esophageal Atresia Repair: Considerations and Advisory Statements. Surg Endosc. 2020.

  120. Terlouw LG, Moelker A, Abrahamsen J, Acosta S, Bakker OJ, Baumgartner I, Boyer L, Corcos O, van Dijk LJ, Duran M, Geelkerken RH, Illuminati G, Jackson RW, Karkkainen JM, Kolkman JJ, Lonn L, Mazzei MA, Nuzzo A, Pecoraro F, Raupach J, Verhagen HJ, Zech CJ, van Noord D, Bruno MJ. European Guidelines on Chronic Mesenteric Ischaemia - Joint United European Gastroenterology, European Association for Gastroenterology, Endoscopy and Nutrition, European Society of Gastrointestinal and Abdominal Radiology, Netherlands Association of Hepatogastroenterologists, Hellenic Society of Gastroenterology, Cardiovascular and Interventional Radiological Society of Europe, and Dutch Mesenteric Ischemia Study Group Clinical Guidelines on the Diagnosis and Treatment of Patients with Chronic Mesenteric Ischaemia. United European Gastroenterol J. 2020;8(4):371-95.

  121. Terlouw LG, van Noord D, van Walsum T, Bruno MJ, Moelker A. Mesenteric Artery Calcium Scoring: A Potential Screening Method for Chronic Mesenteric Ischemia. Eur Radiol. 2020.

  122. Terlouw LG, Verbeten M, van Noord D, Brusse-Keizer M, Beumer RR, Geelkerken RH, Bruno MJ, Kolkman JJ, Dutch Mesenteric Ischemia Study G. The Incidence of Chronic Mesenteric Ischemia in the Well-Defined Region of a Dutch Mesenteric Ischemia Expert Center. Clin Transl Gastroenterol. 2020;11(8):e00200.

  123. Thomeer MG, Vanhooymissen I, Braun LMM, van Koeverden S, Willemssen FE, De Man RA, Ijzermans JN, Dwarkasing RS. Response to Letter: Intrapatient Comparison of the Hepatobiliary Phase of Gd-Bopta and Gd-Eob-Dtpa in the Differentiation of Hca from Fnh. J Magn Reson Imaging. 2020;52(4):1281-2.

  124. Timmerhuis HC, van Dijk SM, Verdonk RC, Bollen TL, Bruno MJ, Fockens P, van Hooft JE, Voermans RP, Besselink MG, van Santvoort HC, Dutch Pancreatitis Study G. Various Modalities Accurate in Diagnosing a Disrupted or Disconnected Pancreatic Duct in Acute Pancreatitis: A Systematic Review. Dig Dis Sci. 2020.

  125. Toes-Zoutendijk E, Kooyker AI, Dekker E, Spaander MCW, Opstal-van Winden AWJ, Ramakers C, Buskermolen M, van Vuuren AJ, Kuipers EJ, van Kemenade FJ, Velthuysen MF, Thomeer MGJ, van Veldhuizen H, van Ballegooijen M, Nagtegaal ID, de Koning HJ, van Leerdam ME, Lansdorp-Vogelaar I, Dutch National Colorectal Cancer Screening Working G. Incidence of Interval Colorectal Cancer after Negative Results from First-Round Fecal Immunochemical Screening Tests, by Cutoff Value and Participant Sex and Age. Clin Gastroenterol Hepatol. 2020;18(7):1493-500.

  126. Umans DS, Hallensleben ND, Verdonk RC, Bouwense SAW, Fockens P, van Santvoort HC, Voermans RP, Besselink MG, Bruno MJ, van Hooft JE, Dutch Pancreatitis Study G. Recurrence of Idiopathic Acute Pancreatitis after Cholecystectomy: Systematic Review and Meta-Analysis. Br J Surg. 2020;107(3):191-9.

  127. Umans DS, Timmerhuis HC, Hallensleben ND, Bouwense SA, Anten MG, Bhalla A, Bijlsma RA, Boermeester MA, Brink MA, Hol L, Bruno MJ, Curvers WL, van Dullemen HM, van Eijck BC, Erkelens GW, Fockens P, van Geenen EJM, Hazen WL, Hoge CV, Inderson A, Kager LM, Kuiken SD, Perk LE, Poley JW, Quispel R, Romkens TE, van Santvoort HC, Tan AC, Thijssen AY, Venneman NG, Vleggaar FP, Voorburg AM, van Wanrooij RL, Witteman BJ, Verdonk RC, Besselink MG, van Hooft JE, Dutch Pancreatitis Study G. Role of Endoscopic Ultrasonography in the Diagnostic Work-up of Idiopathic Acute Pancreatitis (Picus): Study Protocol for a Nationwide Prospective Cohort Study. BMJ Open. 2020;10(8):e035504.

  128. Vale Rodrigues R, Sladek M, Katsanos K, van der Woude CJ, Wei J, Vavricka SR, Teich N, Ellul P, Savarino E, Chaparro M, Beaton D, Oliveira AM, Fragaki M, Shitrit AB, Ramos L, Karmiris K, investigators EC. Diagnosis and Outcome of Oesophageal Crohn's Disease. J Crohns Colitis. 2020;14(5):624-9.

  129. Valkema MJ, van der Wilk BJ, Eyck BM, Wijnhoven BPL, Spaander MCW, Doukas M, Lagarde SM, Schreurs WMJ, Roef MJ, van Lanschot JJB, Valkema R. Surveillance of Clinically Complete Responders Using Serial (18)F-Fdg Pet/Ct Scans in Patients with Esophageal Cancer after Neoadjuvant Chemoradiotherapy. J Nucl Med. 2020.

  130. van Campenhout MJH, van Bommel F, Pfefferkorn M, Fischer J, Deichsel D, Boonstra A, van Vuuren AJ, Berg T, Hansen BE, Janssen HLA. Serum Hepatitis B Virus Rna Predicts Response to Peginterferon Treatment in Hbeag-Positive Chronic Hepatitis B. J Viral Hepat. 2020;27(6):610-9.

  131. van de Ven SE, Falger JM, Verhoeven RH, Baatenburg de Jong RJ, Spaander MC, Bruno MJ, Koch AD. Increased Risk of Second Primary Tumours in Patients with Oesophageal Squamous Cell Carcinoma: A Nationwide Study in a Western Population. United European Gastroenterol J. 2020:2050640620977129.

  132. van de Ven SEM, Snijders M, Bruno MJ, Koch AD. Effectiveness of Topical Budesonide in Preventing Esophageal Strictures after Endoscopic Resection of Esophageal Cancer. Endosc Int Open. 2020;8(12):E1795-E803.

  133. van der Bogt RD, van der Wilk BJ, Poley JW, Krishnadath KK, Schoon EJ, Oostenbrug LE, Siersema PD, Vleggaar FP, Bruno MJ, Biermann K, van Lanschot JJB, Spaander MCW. Endoscopic Ultrasound and Fine-Needle Aspiration for the Detection of Residual Nodal Disease after Neoadjuvant Chemoradiotherapy for Esophageal Cancer. Endoscopy. 2020;52(3):186-92.

  134. van der Bogt RD, van der Wilk BJ, van Lanschot JJB, Spaander MCW. Reply to Rizzatti Et Al. Endoscopy. 2020;52(4):317.

  135. van der Giessen J, Binyamin D, Belogolovski A, Frishman S, Tenenbaum-Gavish K, Hadar E, Louzoun Y, Peppelenbosch MP, van der Woude CJ, Koren O, Fuhler GM. Modulation of Cytokine Patterns and Microbiome During Pregnancy in Ibd. Gut. 2020;69(3):473-86.

  136. van der Wiel SE, May A, Poley JW, Grubben M, Wetzka J, Bruno MJ, Koch AD. Preliminary Report on the Safety and Utility of a Novel Automated Mechanical Endoscopic Tissue Resection Tool for Endoscopic Necrosectomy: A Case Series. Endosc Int Open. 2020;8(3):E274-E80.

  137. van der Wilk BJ, Eyck BM, Doukas M, Spaander MCW, Schoon EJ, Krishnadath KK, Oostenbrug LE, Lagarde SM, Wijnhoven BPL, Looijenga LHJ, Biermann K, van Lanschot JJB. Residual Disease after Neoadjuvant Chemoradiotherapy for Oesophageal Cancer: Locations Undetected by Endoscopic Biopsies in the Presano Trial. Br J Surg. 2020;107(13):1791-800.

  138. Van der Woude CJ. Preface: Pregnancy in Gi-Disorders. Best Pract Res Clin Gastroenterol. 2020;44-45:101672.

  139. van Dijk LJD, Terlouw LG, van Noord D, Bijdevaate DC, Bruno MJ, Moelker A. Endovascular Pressure Measurements to Assess the Functional Severity of Mesenteric Arterial Stenoses. J Vasc Interv Radiol. 2020;31(3):430-7.

  140. van Dijk LJD, van Noord D, van Mierlo M, Bijdevaate DC, Bruno MJ, Moelker A. Single-Center Retrospective Comparative Analysis of Transradial, Transbrachial, and Transfemoral Approach for Mesenteric Arterial Procedures. J Vasc Interv Radiol. 2020;31(1):130-8.

  141. van Riet PA, Erler NS, Bruno MJ, Cahen DL. Comparison of Fine-Needle Aspiration and Fine-Needle Biopsy Devices for Endoscopic Ultrasound-Guided Sampling of Solid Lesions: A Systemic Review and Meta-Analysis. Endoscopy. 2020.

  142. van Riet PA, Giorgio Arcidiacono P, Petrone M, Quoc Nguyen N, Kitano M, Chang K, Larghi A, Iglesias-Garcia J, Giovannini M, van der Merwe S, Santo E, Baldaque-Silva F, Bucobo JC, Bruno MJ, Aslanian HR, Cahen DL, Farrell J. Combined Versus Single Use 20 G Fine-Needle Biopsy and 25 G Fine-Needle Aspiration for Endoscopic Ultrasound-Guided Tissue Sampling of Solid Gastrointestinal Lesions. Endoscopy. 2020;52(1):37-44.

  143. van Riet PA, Quispel R, Cahen DL, Snijders-Kruisbergen MC, van Loenen P, Erler NS, Poley JW, van Driel L, Mulder SA, Veldt BJ, Leeuwenburgh I, Anten MGF, Honkoop P, Thijssen AY, Hol L, Hadithi M, Fitzpatrick CE, Schot I, Bergmann JF, Bhalla A, Bruno MJ, Biermann K. Diagnostic Yield and Agreement on Fine-Needle Specimens from Solid Pancreatic Lesions : Comparing the Smear Technique to Liquid-Based Cytology. Endosc Int Open. 2020;8(2):E155-E62.

  144. Vanwolleghem T, Groothuismink ZMA, Kreefft K, Hung M, Novikov N, Boonstra A. Hepatitis B Core-Specific Memory B Cell Responses Associate with Clinical Parameters in Patients with Chronic Hbv. J Hepatol. 2020;73(1):52-61.

  145. Vermeulen BD, de Zwart M, Sijben J, Soons E, van der Weerd L, Arese D, von den Hoff DW, Craviotto V, Tan A, Groenen MJM, Bogte A, Repici A, Spaander MCW, Siersema PD. Risk Factors and Clinical Outcomes of Endoscopic Dilation in Benign Esophageal Strictures: A Long-Term Follow-up Study. Gastrointest Endosc. 2020;91(5):1058-66.

  146. Vermeulen BD, van der Leeden B, Ali JT, Gudbjartsson T, Hermansson M, Low DE, Adler DG, Botha AJ, D'Journo XB, Eroglu A, Ferri LE, Gubler C, Haveman JW, Kaman L, Kozarek RA, Law S, Loske G, Lindenmann J, Park JH, Richardson JD, Salminen P, Song HY, Soreide JA, Spaander MCW, Tarascio JN, Tsai JA, Vanuytsel T, Rosman C, Siersema PD, Benign Esophageal Perforation Collaborative G. Early Diagnosis Is Associated with Improved Clinical Outcomes in Benign Esophageal Perforation: An Individual Patient Data Meta-Analysis. Surg Endosc. 2020.

  147. Voskuil MD, Spekhorst LM, van der Sloot KWJ, Jansen BH, Dijkstra G, van der Woude CJ, Hoentjen F, Pierik MJ, van der Meulen AE, de Boer NKH, Lowenberg M, Oldenbrug B, Festen EAM, Weersma RK, Parelsnoer I, the Dutch Initiative on C, Colitis. Genetic Risk Scores Identify Genetic Aetiology of Inflammatory Bowel Disease Phenotypes. J Crohns Colitis. 2020.

  148. Vuik FER, Nieuwenburg SAV, Moen S, Schreuders EH, Oudkerk Pool MD, Peterse EFP, Spada C, Epstein O, Fernandez-Urien I, Hofman A, Kuipers EJ, Spaander MCW. Population-Based Prevalence of Gastrointestinal Abnormalities at Colon Capsule Endoscopy. Clin Gastroenterol Hepatol. 2020.

  149. Wieringa JW, van der Woude CJ. Effect of Biologicals and Jak Inhibitors During Pregnancy on Health-Related Outcomes in Children of Women with Inflammatory Bowel Disease. Best Pract Res Clin Gastroenterol. 2020;44-45:101665.

  150. Wieten E, de Klerk CM, Lansdorp-Vogelaar I, Bossuyt PM, Dekker E, Spaander MCW. A Quarter of Participants with Advanced Neoplasia Have Discordant Results from 2-Sample Fecal Immunochemical Tests for Colorectal Cancer Screening. Clin Gastroenterol Hepatol. 2020;18(8):1805-11 e1.

  151. Zhang X, Eyck BM, Yang Y, Liu J, Chao YK, Hou MM, Hung TM, Pang Q, Yu ZT, Jiang H, Law S, Wong I, Lam KO, van der Wilk BJ, van der Gaast A, Spaander MCW, Valkema R, Lagarde SM, Wijnhoven BPL, van Lanschot JJB, Li Z. Accuracy of Detecting Residual Disease after Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Carcinoma (Presino Trial): A Prospective Multicenter Diagnostic Cohort Study. BMC Cancer. 2020;20(1):194.





  156. 21-01-2020. Louisa van Dijk. Chronic mesenteric ischeamia in the picture. Promotoren: Prof.dr. M.J. Bruno, Prof.dr. G.P. Krestin. Copromotoren: Dr. D. Leemreis, Dr. A. Moelker.

  157. 10-03-2020: Maren Harms. Prognosis and Treatment of Primary Biliary Cholangitis. Promotor: Prof.dr. H.J. Metselaar. Copromotor: Dr. H.R. van Buuren, Dr. B.E. Hansen.

  158. 01-09-2020. Lauke Boeijen. Human immune responses during hepatitis B viral load fluctuations. Promotor: Prof.dr. H.J. Metselaar. Copromotor: Dr. A. Boonstra.

  159. 08-09-2020. Mitchell Lie. Knowledge Gaps in the Management of Patients with Inflammatory Bowel Disease. Promotor: Prof.dr. C.J. van der Woude. Copromotoren: Dr. A.C. de Vries. Dr. G.M. Fuhler.

  160. 16-09-2020. Nynke Borren. Quality of life in Inflammatory Bowel Disease: when IBD goes beyond the gut. Promotor: Prof.dr. C.J. van der Woude. Copromotor: Dr. A.N. Ananthakrishna

  161. 25-09-2020. Loes Alferink. Liver health in the general population. The role of diet, body composition and the gut microbiome. Promotoren: Prof.dr. H.J. Metselaar, Prof.dr. J.C. Kiefte-de Jong. Copromotor: Dr. S. Darwish Murad.

  162. 21-10-2020. Rosalie Oey. Studies in Advanced Chronic Liver Disease. Promotor: Prof.dr. H.J. Metselaar. Copromotor: Dr. H.R. van Buuren.

  163. 27-10-2020. Vincent Janmaat. Carcigonesis, prediction and palliative treatment of gastrointestinal cancer. Promotoren: Prof.dr. M. Peppelenbosch, Prof.dr. M.J. Bruno. Copromotoren: Prof.dr. V.M.C.W. Spaander, Dr. G.M. Fuhler.

  164. 28-10-2020. Floor Vergouwe: Long term follow up after esophageal atresia repair: fysical growth and gastrointestinal morbidity. Promotoren: Prof.dr. M.J. Bruno, Prof.dr. R.M.H. Wijnen. Copromotoren: Prof.dr. V.M.C.W. Spaander, Dr. H. IJsselstijn

  165. 11-12-2020. Pavel Taimr. Contrast-enhanced ultrasound in focal liver lesions. Promotoren: Prof.dr. R.A. de Man, Prof.dr. J.N.M. IJzermans.